DE60032927D1 - Verfahren and zusammenstellungen, die renilla gfp enthalten - Google Patents

Verfahren and zusammenstellungen, die renilla gfp enthalten

Info

Publication number
DE60032927D1
DE60032927D1 DE60032927T DE60032927T DE60032927D1 DE 60032927 D1 DE60032927 D1 DE 60032927D1 DE 60032927 T DE60032927 T DE 60032927T DE 60032927 T DE60032927 T DE 60032927T DE 60032927 D1 DE60032927 D1 DE 60032927D1
Authority
DE
Germany
Prior art keywords
processes
compositions containing
renilla gfp
containing renilla
gfp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60032927T
Other languages
English (en)
Other versions
DE60032927T2 (de
Inventor
David Anderson
Beau Robert Peelle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rigel Pharmaceuticals Inc
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Publication of DE60032927D1 publication Critical patent/DE60032927D1/de
Application granted granted Critical
Publication of DE60032927T2 publication Critical patent/DE60032927T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/42—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a HA(hemagglutinin)-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
DE60032927T 1999-11-10 2000-11-10 Verfahren and zusammenstellungen, die renilla gfp enthalten Expired - Lifetime DE60032927T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16459299P 1999-11-10 1999-11-10
US164592P 1999-11-10
PCT/US2000/030915 WO2001034824A2 (en) 1999-11-10 2000-11-10 Methods and compositions comprising renilla gfp

Publications (2)

Publication Number Publication Date
DE60032927D1 true DE60032927D1 (de) 2007-02-22
DE60032927T2 DE60032927T2 (de) 2007-11-08

Family

ID=22595184

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60032927T Expired - Lifetime DE60032927T2 (de) 1999-11-10 2000-11-10 Verfahren and zusammenstellungen, die renilla gfp enthalten

Country Status (7)

Country Link
EP (1) EP1228233B1 (de)
JP (1) JP2003513672A (de)
AU (1) AU1482101A (de)
CA (1) CA2390011A1 (de)
DE (1) DE60032927T2 (de)
DK (1) DK1228233T3 (de)
WO (1) WO2001034824A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338782B2 (en) 1998-12-11 2008-03-04 Clontech Laboratories, Inc. Nucleic acids encoding chromophores/fluorophores and methods for using the same
US9834584B2 (en) 1998-12-11 2017-12-05 Takara Bio Usa, Inc. Nucleic acids encoding chromophores/fluorophores and methods for using the same
US20030087492A1 (en) 2001-11-02 2003-05-08 Promos Technologies, Inc. Semiconductor device and method of manufacturing the same
JP2003527833A (ja) 1999-10-14 2003-09-24 クロンテック・ラボラトリーズ・インコーポレーテッド 花虫類に由来する発色団／蛍光体、およびそれらの使用法
AU2002211722B2 (en) 2000-10-12 2007-03-15 Clontech Laboratories, Inc. Nucleic acids encoding stichodactylidae chromoproteins
US6969597B2 (en) 2001-02-21 2005-11-29 Clontech Laboratories, Inc. Nucleic acids encoding non aggregating fluorescent proteins and methods for using the same
CA2461824A1 (en) 2001-10-12 2003-04-17 Clontech Laboratories, Inc. Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same
DE10233082A1 (de) * 2002-07-19 2004-03-04 Amaxa Gmbh Fluoreszierendes Protein
DE10233047A1 (de) * 2002-07-19 2004-02-26 Amaxa Gmbh Verfahren zur Herstellung eines künstlichen Polypeptids und nach diesem Verfahren hergestelltes künstliches Protein
GB0327143D0 (en) * 2003-11-21 2003-12-24 Univ Belfast Assay
KR101441843B1 (ko) * 2005-10-18 2014-09-17 내셔날 쥬이쉬 헬스 조건부 불멸화 장기 줄기 세포 및 상기 세포의 제조 및 사용 방법
US8986702B2 (en) 2008-05-16 2015-03-24 Taiga Biotechnologies, Inc. Antibodies and processes for preparing the same
CA2735522C (en) 2008-08-28 2017-04-18 Taiga Biotechnologies, Inc. Modulators of myc, methods of using the same, and methods of identifying agents that modulate myc
AU2013292330B2 (en) 2012-07-20 2018-07-12 Taiga Biotechnologies, Inc. Enhanced reconstitution and autoreconstitution of the hematopoietic compartment
US9365825B2 (en) 2013-03-11 2016-06-14 Taiga Biotechnologies, Inc. Expansion of adult stem cells in vitro
US10272115B2 (en) 2013-03-11 2019-04-30 Taiga Biotechnologies, Inc. Production and use of red blood cells
US10583156B2 (en) 2016-12-02 2020-03-10 Taiga Biotechnologies, Inc. Nanoparticle formulations
US10149898B2 (en) 2017-08-03 2018-12-11 Taiga Biotechnologies, Inc. Methods and compositions for the treatment of melanoma
BR102019017792A2 (pt) 2019-08-27 2021-11-16 Fundação Oswaldo Cruz Receptáculo proteico, método para produção do receptáculo, método de identificação de patógenos ou de diagnóstico de doenças, e, uso do receptáculo

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995007463A1 (en) * 1993-09-10 1995-03-16 The Trustees Of Columbia University In The City Of New York Uses of green fluorescent protein
DE69722176T2 (de) * 1996-01-23 2004-03-18 The Board Of Trustees Of The Leland Stanford Junior University, Palo Alto Verfahren zur suche nach transdominanten effektorpeptiden und rna-molekülen
US6232107B1 (en) * 1998-03-27 2001-05-15 Bruce J. Bryan Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
CA2396626A1 (en) * 1999-11-12 2001-05-17 Rigel Pharmaceuticals, Inc. Methods and compositions for screening using diphtheria toxin constructs
JP4830063B2 (ja) * 2000-03-15 2011-12-07 プロルーム・リミテッド Ｒｅｎｉｌｌａｒｅｎｉｆｏｒｍｉｓ蛍光タンパク質、その蛍光タンパク質をコードする核酸、および診断、ハイスループットスクリーニングおよび新規アイテムにおけるその使用

Also Published As

Publication number Publication date
CA2390011A1 (en) 2001-05-17
JP2003513672A (ja) 2003-04-15
EP1228233B1 (de) 2007-01-10
AU1482101A (en) 2001-06-06
WO2001034824A2 (en) 2001-05-17
EP1228233A2 (de) 2002-08-07
DE60032927T2 (de) 2007-11-08
DK1228233T3 (da) 2007-05-14
WO2001034824A3 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
DE60032927D1 (de) Verfahren and zusammenstellungen, die renilla gfp enthalten
DE60231548D1 (de) N; formkörper und verfahren zu ihrer herstellung
DE122006000035I2 (de) Nd verfahren zu seiner herstellung
DE60233058D1 (de) Silsesquioxanderivate und verfahren zu ihrer herstellung
DE60115902D1 (de) Osteoimplantat und verfahren zu seiner herstellung
DE60031949D1 (de) Leiterplatte und verfahren zu ihrer herstellung
ATA10852001A (de) Bauelement und verfahren zu seiner herstellung
DE60027698D1 (de) Lasttragendes osteoimplantat und verfahren zu seiner herstellung
DE50214717D1 (de) Und verfahren zu seiner herstellung
DE50103010D1 (de) Induktives bauelement und verfahren zu seiner herstellung
AT501583B8 (de) Dualband-antenne und verfahren zu ihrer herstellung
DE69929311D1 (de) Oximanderivate und verfahren zu ihrer herstellung
DE60129522D1 (de) Gipszusammensetzungen und dazugehörende verfahren
DE69930254D1 (de) Mikroströmungstechnischer gebenstand und verfahren zu seiner herstellung
DE60136793D1 (de) Elektrostatisches spannfutterglied und verfahren zu seiner herstellung
DE60326074D1 (de) Im mund zerfallende tabletten und verfahren zu ihrer herstellung.
DE60013027D1 (de) Bauteil und Verfahren zu seiner Herstellung
ATE343627T1 (de) Riechstoffkompositionen mit erhöhter viskosität und verfahren zu ihrer herstellung
DE69922815D1 (de) Gipsplatte und verfahren zu ihrer herstellung
ATE554113T1 (de) Butencopolymere und verfahren zu ihrer herstellung
DE60111195D1 (de) Wässerige formulierungen und verfahren zu ihrer herstellung
ATE259162T1 (de) Zusammensetzungen die kreatin in form einer suspension enthalten
DE60116486D1 (de) Gallengangstent und verfahren zu seiner herstellung
ATE327981T1 (de) Arylisoxazolin-derivative, verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfungsmittel
ATE469138T1 (de) Aminoalkykbenzoyl-benzofurane oder benzothiophene,verfahren zu ihrer herstellung und die enthaltende zusammensetzungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition